¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
ÇÊÅÍ ´Ïµé ½ÃÀå ¼ºÀå ¹× µ¿Çâ :
Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼¿¡ µû¸£¸é ¼¼°è ÇÊÅÍ ´Ïµé ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÌ ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö CAGR 7.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í·É Àα¸ Áõ°¡, ±â¼ú ¹ßÀü, ¸¸¼º »óóÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¼¼°èÀûÀ¸·Î ´Ù¾çÇÑ ¸¸¼º »óóÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀϹÝÀûÀÎ ¸¸¼º »óó¿¡´Â ´ç´¢º´¼º Á·ºÎ ±Ë¾ç, Á¤¸Æ¼º ÇÏÁö ±Ë¾ç, ¿åâ µîÀÌ ÀÖ½À´Ï´Ù.
´ç´¢º´¼º Á·ºÎ±Ë¾çÀº ÀϹÝÀûÀ¸·Î ´ç´¢º´ÀÇ Àå±âÈ¿Í È¯ÀÚÀÇ ÀúÇ÷´çÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ¼¼°è ¸ðµç ¿¬·ÉÃþ¿¡¼ ´ç´¢º´ÀÇ ºñÀ²ÀÌ Áõ°¡ÇÏ´Â °ÍÀÌ ´ç´¢º´¼º Á·ºÎ ±Ë¾ç À¯º´·üÀÌ ³ôÀº ÁÖ¿ä ¿øÀÎÀÔ´Ï´Ù. ¹Ì±¹ ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI)ÀÇ Á¶»ç¿¡ µû¸£¸é 2017³â ºÏ¹ÌÀÇ ´ç´¢º´¼º Á·ºÎ±Ë¾ç À¯º´·üÀº 13.0%(ÃÖ°í), ¾Æ½Ã¾Æ 5.5%, ¾ÆÇÁ¸®Ä« 7.2%, À¯·´ 5.1%, È£ÁÖ 1.5%, º§±â¿¡ 16.6%, ij³ª´Ù 14.8%, ¹Ì±¹ 13.0%·Î ³ªÅ¸³µ½À´Ï´Ù.
¿å⠹߻ý·üÀº ±Þ¼ÓÇÑ °í·ÉÈ¿Í ¼¼°è Àå¾ÖÀÎ Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖÀ¸¸ç, NCBI¿¡ µû¸£¸é ¹Ì±¹¿¡¼´Â ¿¬°£ ¾à 110¾ï ´Þ·¯°¡ ¿åâÀ¸·Î ÀÎÇØ ÁöÃâµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ä¾ç¿ø ȯÀÚÀÇ ¿åâ À¯º´·üÀº ¸Å³â ¾à 11.0%·Î ¿¹Ãø ±â°£ µ¿¾È ¿å⠹߻ý·ü°ú À¯º´·üÀÌ ³ô¾ÆÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤¸Æ¼º ÇÏÅðºÎ ±Ë¾çÀº ÁÖ·Î Á¤¸Æ ÁúȯÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â Á·°üÀý°ú ¹«¸ »çÀÌÀÇ °³¹æ¼º º´º¯ÀÔ´Ï´Ù. °¡Àå ÈçÇÑ ÇÏÅðºÎ ±Ë¾çÀ̸ç, NCBI¿¡ µû¸£¸é Á¤¸Æ¼º ÇÏÅðºÎ ±Ë¾çÀÇ À¯º´·üÀº 0.18%-1.0%ÀÔ´Ï´Ù. Á¤¸Æ¼º ÇÏÅðºÎ ±Ë¾çÀº ¸¸¼º Á¤¸Æ ÁúȯÀÇ °¡Àå ÁøÇà µÈ ÇüÅÂÀ̸ç Àç¹ß·üÀÌ 70.0% ÀÌ»óÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼º »óóÀÇ ³ôÀº À¯º´·üÀº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÇÊÅÍ´Ïµé ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
- ¼öÀÍ Ãø¸é¿¡¼ ½ºÅ×Àθ®½º ½ºÆ¿ ºÎ¹®Àº ÀÌ Á¦Ç°À» Á¦°øÇÏ´Â ¿©·¯ ±â¾÷ÀÇ Á¸Àç¿Í Àú·ÅÇÑ °¡°ÝÀ¸·Î ÀÎÇØ 2022³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
- º´¿ø ºÎ¹®Àº ¼¼°è º´¿ø ¼ö Áõ°¡·Î ÀÎÇØ 2022³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
- ¾ÆÅÂÁö¿ªÀº ±³Åë »ç°í Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀåÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÇÊÅÍ ´Ïµé ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ½ÃÀå °èÅë Àü¸Á
- »óÀ§ ½ÃÀå Àü¸Á
- °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
- º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ÇÊÅÍ ´Ïµé ½ÃÀå ºÐ¼® Åø
- ¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
- PESTEL ºÐ¼®
Á¦4Àå ÇÊÅÍ ´Ïµé : ¿øÀç·á ÃßÁ¤¡¤µ¿Ç⠺м®
- ÇÊÅÍ ´Ïµé ½ÃÀå, Áß¿ä Æ÷ÀÎÆ®
- ÇÊÅÍ ´Ïµé ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
- ½ºÅ×Àθ®½º ½ºÆ¿
- À¯¸®
- ±âŸ
Á¦5Àå ÇÊÅÍ ´Ïµé : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®
- ÇÊÅÍ ´Ïµé ½ÃÀå, Áß¿ä Æ÷ÀÎÆ®
- ÇÊÅÍ ´Ïµé ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
- º´¿ø
- Ŭ¸®´Ð
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
- ±âŸ
Á¦6Àå ÇÊÅÍ ´Ïµé ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®
- Áö¿ªº° Àü¸Á
- Áö¿ªº° ÇÊÅÍ ´Ïµé ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
- ºÏ¹Ì
- ½ÃÀå Ã߻ꡤ¿¹Ãø, 2018-2030³â
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- ¿µ±¹
- µ¶ÀÏ
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- µ§¸¶Å©
- ½º¿þµ§
- ³ë¸£¿þÀÌ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ÀϺ»
- Áß±¹
- Àεµ
- È£ÁÖ
- ű¹
- Çѱ¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- Äí¿þÀÌÆ®
Á¦7Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
- ȸ»ç/°æÀï ºÐ·ù
- BD
- Cardinal Health
- Myco Medical
- Stryker
- B.Braun SE
- Sol-Millennium
- Terumo Corporation
- ICU Medical Inc.
LSH 23.10.27
Filter Needles Market Growth & Trends:
The global filter needles market size is expected to reach USD 2.9 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.5% from 2023 to 2030. The increasing geriatric population, technological advancements, and rising prevalence of chronic wounds are the key factors driving the market. The increasing prevalence of various chronic wounds across the globe is anticipated to drive the market over the forecast period. Some of the prevailing chronic wounds are diabetic foot ulcers, venous leg ulcers, and pressure ulcers.
Diabetic foot ulcers generally occur due to prolonged diabetes or low blood glucose level in patients. The increasing rate of diabetes in all age groups across the globe is a major factor responsible for the high prevalence of diabetic foot ulcers. As per studies conducted by the National Center for Biotechnology Information (NCBI), in 2017, the prevalence rate of diabetic foot ulcers in North America was 13.0% (highest), 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, 1.5% in Australia, 16.6% in Belgium, 14.8% in Canada, and 13.0% in the U.S.
The incidence rate of pressure ulcers is rising owing to a rapidly aging population and an increase in the incidence of disabilities across the globe. In the U.S., around USD 11.0 billion is spent per year on pressure ulcers, as per the NCBI. Furthermore, the prevalence rate of pressure ulcers in nursing home patients is around 11.0% every year, therefore incidence and prevalence are anticipated to be high over the forecast period. A venous leg ulcer is an open lesion between the ankle joint and knees mainly caused due to venous disease. It is the most common leg ulcer and the prevalence rate of venous leg ulcers ranges from 0.18% to 1.0%, as per NCBI. Venous leg ulcers are the most advanced form of chronic venous disorders and the recurrence rate of these ulcers is more than 70.0%. Such a high prevalence of chronic wounds is expected to boost market growth over the forecast period.
Filter Needles Market Report Highlights:
- In terms of revenue, the stainless steel segment held the largest market share in 2022 due to the presence of several players offering this product and low price
- The hospitals segment held the largest revenue share in 2022 owing to the increasing number of hospitals across the globe
- In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period owing to the rising road accident cases in this region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Raw material
- 1.1.2. End use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Raw material outlook
- 2.2.2. End use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Filter Needles Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Filter Needles Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Filter Needles: Raw Material Estimates & Trend Analysis
- 4.1. Filter Needles Market, Key Takeaways
- 4.2. Filter Needles Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Stainless Steel
- 4.3.1. Stainless steel market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Glass
- 4.4.1. Glass market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Others
- 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Filter Needles: End Use Estimates & Trend Analysis
- 5.1. Filter Needles Market, Key Takeaways
- 5.2. Filter Needles Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Hospitals
- 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Clinics
- 5.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Ambulatory Surgery Centers
- 5.5.1. Ambulatory surgery centers market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Filter Needles Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Filter Needles Market by Region: Key Takeaways
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Denmark
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Norway
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.2.1. BD
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Cardinal Health
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Myco Medical
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Stryker
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. B.Braun SE
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Sol-Millennium
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Terumo Corporation
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. ICU Medical Inc.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives